<scp>NAT10</scp> Knockdown Improves Cisplatin Sensitivity in Non‐Small Cell Lung Cancer by Inhibiting the <scp>TRIM44</scp>/<scp>PI3K</scp>/<scp>AKT</scp> Pathway
NAT10 knockdown improved DDP sensitivity in NSCLC by inhibiting the TRIM44/PI3K/AKT pathway, which may have significant clinical implications for overcoming DDP resistance in NSCLC treatment.
Authors
- Yuan Weng
- Kejia Yang (ORCID: https://orcid.org/0009-0005-7217-7694)
- Qi Sun (ORCID: https://orcid.org/0009-0006-5197-8641)
- Ye Wang (ORCID: https://orcid.org/0000-0002-5675-2733)
- Xiansong Yang
Institutions
- Qingdao University (CN)
- Wuxi Fourth People's Hospital (CN)
- Affiliated Hospital of Qingdao University (CN)
Publication Details
- Journal
- Thoracic Cancer
- Published
- 2025-05-01
- DOI
- https://doi.org/10.1111/1759-7714.70079
- Citations
- 3
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 2.42